Skip to main content
. 2014 Apr 29;2014(4):CD010071. doi: 10.1002/14651858.CD010071.pub3

NCT01518335.

Trial name or title A double blind, randomised, placebo controlled study evaluating the use of platelet rich plasma therapy for acute ankle sprains in the Emergency Department
Methods Study design: randomised trial
 Random sequence generation: not reported
 Allocation concealment: not reported
 Masking: double blind (subject, caregiver)
Participants Location: not reported
 Target sample size (N): 38
 Inclusion criteria: severe ankle sprain, X‐ray completed
 Exclusion criteria: pregnancy/breastfeeding; police custody; active infection; metastatic disease/tumours; history of thrombocytopenia; allergy to ester or amine anaesthetics; taking anticoagulant medication; peripheral vascular disease; known coagulopathy
Interventions PRP: platelet rich plasma injection (details not reported)
Controls or placebo or no intervention (standard care): standard care
Outcomes Primary outcomes: LEFS
 Secondary outcomes: change in pain from baseline (details not reported)
 Timing of outcomes measurement: day 0; days 2‐3, days 8‐10, day 30
Starting date Main ID: NCT01518335Date of registration: December 2011
Last refreshed on: February 2013
 Date of first enrolment: June 2009
 Status: completed
Contact information Name: Adam Rowden
 Address: not reported
 Telephone: not reported
 Email: not reported
 Affiliation: Einstein Healthcare Network
Notes